CYT387 (momelotinib)
Showing 1 - 22 of 22
Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide
Completed
- Primary Myelofibrosis
- +4 more
-
Scottsdale, Arizona
- +21 more
Jan 18, 2021
Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV) Myelofibrosis, Postessential Thrombocythemia (Post-ET)
Completed
- Primary Myelofibrosis (PMF)
- +2 more
-
Phoenix, Arizona
- +12 more
Jan 12, 2021
Polycythemia Vera, Essential Thrombocythemia Trial in Worldwide (Momelotinib)
Terminated
- Polycythemia Vera
- Essential Thrombocythemia
-
Scottsdale, Arizona
- +14 more
Apr 14, 2020
Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) Trial
Completed
- Primary Myelofibrosis (PMF)
- +2 more
- Momelotinib
- Best Available Therapy (BAT)
-
Los Angeles, California
- +47 more
Apr 1, 2020
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Active, not recruiting
- Primary Myelofibrosis
- +2 more
- Momelotinib
- +3 more
-
Phoenix, Arizona
- +166 more
Jan 27, 2022
EGFR Mutated EGFR TKI Naive Metastatic NSCLC Trial in Duarte, Palo Alto, Whittier (Momelotinib (MMB), Erlotinib)
Terminated
- EGFR Mutated EGFR TKI Naive Metastatic NSCLC
- Momelotinib (MMB)
- Erlotinib
-
Duarte, California
- +2 more
Jan 30, 2019
Metastatic Pancreatic Ductal Adenocarcinoma Trial in United States (Momelotinib, Placebo to match momelotinib, Nab-paclitaxel)
Terminated
- Metastatic Pancreatic Ductal Adenocarcinoma
- Momelotinib
- +3 more
-
Los Angeles, California
- +3 more
Jan 31, 2019
Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma Trial in United States (Momelotinib (MMB), Capecitabine,
Terminated
- Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma
- Momelotinib (MMB)
- +2 more
-
Scottsdale, Arizona
- +3 more
Jan 30, 2019
Cancer Target Therapy Efficacy
Active, not recruiting
- Cancer
- RNA sequencing
- +5 more
-
Walnut, California
- +6 more
Sep 13, 2021
Relapsed Metastatic KRAS-Mutated NSCLC Trial in United States (Momelotinib (MMB), Trametinib)
Terminated
- Relapsed Metastatic KRAS-Mutated Non-Small Cell Lung Cancer
- Momelotinib (MMB)
- Trametinib
-
Duarte, California
- +4 more
Jan 30, 2019
Multiple Myeloma Trial in United States (Ruxolitinib Oral Tablet [Jakafi], Lenalidomide, Methylprednisolone)
Recruiting
- Multiple Myeloma
- Ruxolitinib Oral Tablet [Jakafi]
- +2 more
-
Alhambra, California
- +12 more
Apr 18, 2022
Behavior, Health Trial (Computer-based Intervention)
Not yet recruiting
- Behavior, Health
- Computer-based Intervention
- (no location specified)
May 18, 2023
Smoking, Tobacco, Smoking, Smoking, Cigarette Trial in Philadelphia (7-11, CVS)
Recruiting
- Smoking, Tobacco
- +2 more
- 7-11
- CVS
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jul 26, 2022
Pleural Effusion, Malignant, Pleural Effusion, Pleura; Exudate Trial in Næstved, Roskilde (Local anesthetic thoracoscopy,
Terminated
- Pleural Effusion, Malignant
- +2 more
- Local anesthetic thoracoscopy
- US-guided pleural biopsy
-
Næstved, Denmark
- +1 more
Sep 24, 2020
Vaping Related Disorder Trial in London (PMT Threat Appraisal, General Nutrition and Lifestyle)
Completed
- Vaping Related Disorder
- PMT Threat Appraisal
- General Nutrition and Lifestyle
-
London, Ontario, CanadaWestern University
Aug 9, 2021
Smoking Cessation Trial in Cardiff (Cytisine)
Terminated
- Smoking Cessation
-
Cardiff, United KingdomSimbec Research Ltd
Oct 17, 2019
Osteoarthritis Trial in Durham (Health Education, Osteoarthritis Self-Management)
Completed
- Osteoarthritis
- Health Education
- Osteoarthritis Self-Management
-
Durham, North CarolinaDurham VA Medical Center, Durham, NC
Apr 6, 2015